EBC vs EW · P/E 11, rev $112.6M vs P/E 47, rev $1.39B
Eastern Bankshares Inc (EBC) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Eastern Bankshares Inc (EBC) is a banks - regional company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EBC revenue for 2024-12-31 was $112.6M. Net income was $119.6M. Revenue was up 46.5% from 2023-12-31 to 2024-12-31. EBC currently screens at market cap $4.33B and trailing P/E 11.1.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EBC currently screens at market cap $4.33B and trailing P/E 11.1. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EBC and EW stock pages for the full models.
Not investment advice.